Action 6547 MEDIGEN VACCINE BIOLOGICS CORPORATION
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Medigen Vaccine Biologics Corporation

Actions

6547

TW0006547003

Cours en clôture Taipei Exchange
Autres places de cotation
 00:00:00 26/04/2024 		Varia. 5j. Varia. 1 janv.
51,3 TWD -1,35% Graphique intraday de Medigen Vaccine Biologics Corporation +5,77% -26,82%
15/03 Medigen Vaccine Biologics Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Medigen Vaccine Biologics Corporation annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
WHO Initiative Signs New Licensing Agreements On Covid-19 Technologies [press release]
Medigen Vaccine Biologics Corporation Provides License Covid-19 Vaccine to WHO C-TAP and UN Medicines Patent Pool
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Medigen Vaccine Biologics Corporation Withdraws Covid-19 Vaccine Provisional Application and Update with Three-Dose Data for Further Review
Medigen Vaccine Biologics Corporation Approves the Election of Ming-Yi ,Wu as Independent Director and Member of Audit and Remuneration Committees
Medigen Vaccine Biologics Corporation Files New Drug Application of MVC EV71 Vaccine to Drug Administration of Vietnam
Medigen Vaccine Biologics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Medigen Vaccine Biologics Corporation Announces Board Changes
Medigen Vaccine Biologics Corporation Announces the Resignation of Chang, Ming-Cheng as Independent Director
Medigen Vaccine Biologics Corporation Receives the NDA Approval Letter of Mvcquadrivalent Influenza Vaccine from Taiwan Food and Drug Administration
Medigen Vaccine Biologics Corporation Announces Results of MVC COVID-19 Vaccine Phase 3 Clinical Trial in Thailand
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Taiwan firm to provide free COVID-19 testing for Japan-bound visitors
Medigen Vaccine Biologics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Medigen Vaccine Biologics : Clarification on media reports
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 6547
  4. Actualités Medigen Vaccine Biologics Corporation
  5. Autres langues